stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. CNC
    stockgist
    HomeTop MoversCompaniesConcepts
    CNC logo

    Centene Corporation

    CNC
    NYSE
    Healthcare
    Medical - Healthcare Plans
    Saint Louis, MO, US60,400 employeescentene.com
    $35.07
    +1.12(3.30%)

    Mkt Cap $17.2B

    $25.21
    $63.86

    52-Week Range

    At a Glance

    AI-generated

    Centene Corporation reported total revenues of $194.78 billion for fiscal year 2025, driven by premium and service revenues of $174.58 billion and premium tax of $20.20 billion.

    Revenue breakdown: Medicaid Segment (57.5%), Commercial Segment (20.2%), Medicare Segment (16.5%).

    8-K
    Centene Corporation appointed Theodore Pienkos as Corporate Controller and Chief Accounting Officer effective March 18, 2026, with a base salary of $440,000 and target bonus of 60% of base salary. Kate Casso, the prior Corporate Controller, was appointed Senior Vice President, Finance Operations and Innovation on the same date as part of leadership development efforts.

    $17.2B

    Market Cap

    $195.1B

    Revenue

    -$6.7B

    Net Income

    Employees60,400
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Medicaid Segment57.5%($1.1T)
    Commercial Segment20.2%($402.2B)
    Medicare Segment16.5%($330.0B)
    All Other Segments5.8%($115.2B)
    Activity

    What Changed Recently

    Management Change
    Mar 23, 2026

    DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS Effective Marc

    Financial Results
    Feb 5, 2026

    , and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange of 1934, as amended. SIGNATURE Pursuant to the requirements of the

    Regulation FD
    Mar 9, 2026

    of this Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of

    Regulation FD
    Feb 22, 2026

    REGULATION FD DISCLOSURE Members of Centene Corporation's (the Company's) senior management team will meet with investors the week of February 23, 2026. Consist

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    RPRXRoyalty Pharma plc$48.57+0.17%$20.8B25.6
    ILMNIllumina, Inc.$127.26+0.50%$19.5B22.3
    HOLXHologic, Inc.$75.62+0.02%$16.9B31.2
    GMABGenmab A/S$27.38+0.59%$16.9B25.2
    THCTenet Healthcare Corporat...$188.02-1.18%$16.5B12.7
    MEDPMedpace Holdings, Inc.$498.68+1.88%$14.2B28.7
    SNNSmith & Nephew plc$32.13+0.11%$13.7B22.0
    FMSFresenius Medical Care AG...$22.43+0.38%$12.9B11.0
    Analyst View
    Company Profile
    CIK0001071739
    ISINUS15135B1017
    CUSIP15135B101
    Phone314 725 4477
    AddressCentene Plaza, Saint Louis, MO, 63105, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice